The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $386,514
- $3,039,910 in all
- Institutions
- 7
- 7 contact PIs
- Patents
- 3
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- BROAD INSTITUTE, INC.1
- INDIANA UNIVERSITY INDIANAPOLIS1
- INSTITUTE FOR SYSTEMS BIOLOGY1
- UNIVERSITY OF MISSISSIPPI MED CTR1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-P (J1))4
- Special Emphasis Panel (ZCA1 RPRB-M (A1))2
- Special Emphasis Panel (ZCA1 GRB-I (A1))1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | (PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors1R01CA194470-01 | Janes, Kevin A | UNIVERSITY OF VIRGINIA, VA | First-year cost $464,569 | Study section ZCA1 |
| FY2015 | (PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors1R01CA194473-01 | Gramatges, Maria Monica | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $386,514 | Study section ZCA1 |
| FY2015 | PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia1R01CA194593-01 | Zimmers, Teresa A | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $366,552 | Study section ZCA1 |
| FY2015 | Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness1R01CA194447-01 | Elshamy, Wael M. | UNIVERSITY OF MISSISSIPPI MED CTR, MS | First-year cost $344,040 | Study section ZCA1 |
| FY2014 | (PQB-4) Single cell analysis strategy for monitoring drug responses of tumors1R01CA190122-01 | Tian, Qiang | INSTITUTE FOR SYSTEMS BIOLOGY, WA | First-year cost $591,830 | Study section ZCA1 |
| FY2014 | PQB-3: Discovery and validation of the driving mediators of cancer cachexia1R01CA190101-01 | Golub, Todd R.Thomas, David | BROAD INSTITUTE, INC., MA | First-year cost $554,405 | Study section ZCA1 |
| FY2014 | (PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto1R01CA190121-01 | Sulman, ErikVerhaak, Roel Gw | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $332,000 | Study section ZCA1 |
Patents from its funded projects
3 patents name 1 of the 7 funded projects.
- US 11,111,296 (opens the patent at USPTO, a PDF, in a new tab)COMPOSITIONS AND METHODS FOR TREATING CARDIAC DYSFUNCTIONGranted September 7, 2021 to The Broad Institute, Inc. and Dana-Farber Cancer Institute, Inc.R01CA190101 · BROAD INSTITUTE, INC., MA
- US 11,058,903 (opens the patent at USPTO, a PDF, in a new tab)METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA USING AN INHIBITOR OF RAGEGranted July 13, 2021 to The Broad Institute, Inc. and Dana-Farber Cancer Institute, Inc.R01CA190101 · BROAD INSTITUTE, INC., MA
- US 10,191,033 (opens the patent at USPTO, a PDF, in a new tab)Compositions and Methods for Identifying and Treating Cachexia or Pre-CachexiaGranted January 29, 2019 to The Broad Institute, Inc. and Dana-Farber Cancer Institute, Inc.R01CA190101 · BROAD INSTITUTE, INC., MA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.